| 1 |
enhancer of zeste homolog 2
(1020 times)
|
Neoplasms
(347 times)
|
PRC2 (119 times)
lncRNAs (53 times)
HCC (45 times)
|
2002 The polycomb group protein EZH2 is involved in progression of prostate cancer.
|
| 2 |
enhancer of zeste 2
(56 times)
|
Neoplasms
(14 times)
|
PRC2 (15 times)
EED (5 times)
SUZ12 (4 times)
|
2004 Polycomb group suppressor of zeste 12 links heterochromatin protein 1alpha and enhancer of zeste 2.
|
| 3 |
enhancer of zeste 2 polycomb repressive complex 2 subunit
(25 times)
|
Neoplasms
(9 times)
|
HCC (4 times)
EMT (2 times)
IRF-1 (2 times)
|
2015 Activation of SAPK/JNK mediated the inhibition and reciprocal interaction of DNA methyltransferase 1 and EZH2 by ursolic acid in human lung cancer cells.
|
| 4 |
enhancer of Zeste, Drosophila, homolog 2
(6 times)
|
Cell Transformation, Neoplastic
(1 time)
|
ET (3 times)
DC (1 time)
DPYD (1 time)
|
2009 EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation.
|
| 5 |
component-enhancer of zeste homolog 2
(1 time)
|
Pigmentation
(1 time)
|
PRC2 (1 time)
|
2016 EZH2 as a mediator of treatment resistance in melanoma.
|
| 6 |
effect of zeste homolog 2
(1 time)
|
Neoplasms
(1 time)
|
WF (1 time)
|
2017 Effect of wound fluid on chemotherapy sensitivity of T24 bladder cancer cells with different enhancer of zeste homolog 2 status.
|
| 7 |
enhancer of zeste 2 polycomb
(1 time)
|
Biochemistry
(1 time)
|
ESCs (1 time)
ME (1 time)
|
2018 Activin/Smad2 and Wnt/beta-catenin up-regulate HAS2 and ALDH3A2 to facilitate mesendoderm differentiation of human embryonic stem cells.
|
| 8 |
enhancer of zeste 2 PRC2 subunit
(1 time)
|
Biochemistry
(1 time)
|
GDF15 (1 time)
PRC2 (1 time)
TEAD (1 time)
|
2018 YAP promotes breast cancer metastasis by repressing growth differentiation factor-15.
|
| 9 |
enhancer of zeste2 gene
(1 time)
|
Biochemistry
(1 time)
|
---
|
2015 Wilms tumor suppressor, WT1, suppresses epigenetic silencing of the beta-catenin gene.
|
| 10 |
Enhancer Zeste of Homolog 2
(1 time)
|
Cell Biology
(1 time)
|
ARMS (1 time)
PKC (1 time)
RMS (1 time)
|
2018 12-O-tetradecanoylphorbol-13-acetate and EZH2 inhibition: A novel approach for promoting myogenic differentiation in embryonal rhabdomyosarcoma cells.
|
| 11 |
expression of ANKRD1 and ANGPTL4 by recruiting zeste homolog 2
(1 time)
|
Cell Biology
(1 time)
|
lncRNAs (1 time)
PC (1 time)
|
2019 RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4.
|
| 12 |
expression of miR-101 and zeste homolog 2
(1 time)
|
Neoplasms
(1 time)
|
FIGO (1 time)
|
2014 miR-101 regulates expression of EZH2 and contributes to progression of and cisplatin resistance in epithelial ovarian cancer.
|
| 13 |
expression through zeste homolog 2
(1 time)
|
Hematology
(1 time)
|
AML (1 time)
HSPCs (1 time)
LSC (1 time)
|
2018 Long noncoding RNA HOTAIR promotes the self-renewal of leukemia stem cells through epigenetic silencing of p15.
|
| 14 |
expressions of PDK1 and of zeste homolog 2
(1 time)
|
Biochemistry
(1 time)
|
ATL-1 (1 time)
EGFR-TKIs (1 time)
HOTAIR (1 time)
|
2018 Repression of PDK1- and LncRNA HOTAIR-Mediated EZH2 Gene Expression Contributes to the Enhancement of Atractylenolide 1 and Erlotinib in the Inhibition of Human Lung Cancer Cells.
|
| 15 |
expressions of zeste homolog 2
(1 time)
|
Biochemistry
(1 time)
|
CRPC (1 time)
DNMT1 (1 time)
HOTAIR (1 time)
|
2018 HOTAIR-mediated reciprocal regulation of EZH2 and DNMT1 contribute to polyphyllin I-inhibited growth of castration-resistant prostate cancer cells in vitro and in vivo.
|
| 16 |
EZH2 histone methyltransferase
(1 time)
|
Medicine
(1 time)
|
---
|
2016 An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation.
|
| 17 |
increased Zeste homolog 2
(1 time)
|
Neoplasms
(1 time)
|
VASH1 (1 time)
|
2010 Regulation of tumor angiogenesis by EZH2.
|
| 18 |
methyltransferase zeste homolog 2
(1 time)
|
Neoplasms
(1 time)
|
DZNep (1 time)
|
2015 Ribavirin as a tri-targeted antitumor repositioned drug.
|
| 19 |
recruiting zeste homolog 2
(1 time)
|
Nucleic Acids
(1 time)
|
BRCA1 (1 time)
IL (1 time)
lncRNA (1 time)
|
2019 lncRNA MALAT1 Accelerates Skeletal Muscle Cell Apoptosis and Inflammatory Response in Sepsis by Decreasing BRCA1 Expression by Recruiting EZH2.
|
A Search Service for Abbreviation / Long Form